The risk of a COVID-19 diagnosis for breast cancer patients is still not completely known. Studies have come that show that cancer patients are more at risk of adverse effects if they develop COVID-19. However, a few studies state that compared to other cancer patients, breast cancer patients are at a lower risk of serious illness. The stage of breast cancer also seems to play a role in one’s risk level.

As with most other events planned for this year, the ASCO 2020 Conference was rescheduled as a virtual event, originally set to be held in Chicago from May 29^th to 31^st. The American Society of Clinical Oncology (ASCO) Conference is a key research conference that brings together clinicians, researchers, and patient advocates from around the world. The conference included over 5,000 abstracts, posters, slides and videos, a day of video broadcasts and around 147 virtual exhibits. While we weren’t able to come together in person this year, ASCO successfully hosted a virtual conference that shared an incredible amount of research that’s relevant to breast cancer patients. Below are some of the highlights.

Individuals diagnosed with cancer have been identified as being at a high-risk of getting seriously ill if they get COVID-19. Data from various studies show that the type of cancer, the stage, the person’s age, health, and other factors contribute to how high-risk a patient may be. In addition to this, the type of treatment a person is receiving and how long their last treatment was, can all impact their outcome. At the same time, a few studies have shown that breast cancer patients fare better, compared to patients with other types of cancers.

In part 1 of our clinical trials series, we explained that clinical trials allow doctors and researchers to test treatments, medical procedures and therapies for various diseases and conditions. In the second part of the series, we debunked 7 common myths on clinical trials. In both parts, we focused on the type of clinical trials most people think of when they hear clinical trials, studies involving drugs. However, clinical trials can study more than just drug treatments or surgeries. According to Clinical Trials Ontario, they can also be conducted to “test devices, genetic therapies, natural health products, psychotherapies, lifestyle and preventive care interventions, and many other things.”

The feeling appears on the heels of a breast cancer diagnosis so quickly I think the doctor delivering the “It is cancer” news should in the same breath say, “For the rest of your life, prepare to surrender any assumptions that you ever held even a modicum of control over your health, you foolish woman.” Certain you’ll never regain your equilibrium, you search desperately for the first thing that hints even slightly as an option to ground and balance you. For many women, that “first thing” is food. Unhealthy, unsustainable dieting habits all start somewhere and unfortunately, fad diets constantly cycle through the breast cancer community.

The COVID-19 pandemic has been particularly concerning and challenging for many cancer patients and their families. As you’ve most likely heard by now, cancer patients and survivors may be at higher risk of complications from COVID-19 because cancer and cancer treatments can contribute to weakened immune systems. This has left many patients with questions on how best to navigate their cancer care, including whether it is safe to continue their treatment, will their health care be de-prioritized by the healthcare system and how they can reduce their risk of contracting the virus.

In part 1 of our blog series on clinical trials, we explained what clinical trials are, why you should participate in them and how to get more information about participating. You may now be familiar with clinical trials but still hesitant about enrolling in one because of certain concerns that you may have. These concerns are valid as many breast cancer patients have these same concerns. However, some of these concerns about clinical trials are ill-informed. In part 2 of our blog series on clinical trials, we debunk some of the most common myths surrounding clinical trials. We hope that this will provide you with some fact-based information to make a more informed decision about whether or not clinical trials are right for you.

Hair loss is something that some women who are diagnosed with breast cancer face. Hair can be a huge part of a person’s identity, especially for a woman. The way your hair looks can communicate a lot to others about the type of person you are. Therefore, it’s understandable that losing your hair following a breast cancer diagnosis can add distress to an already devastating situation. In order to bring some relief and sense of control should you have to deal with hair loss, we outline why and when hair loss occurs as well as things that you can do to get through it.

Two years ago, I had the sincere pleasure of attending my first oncology nutrition symposium, a biennial event hosted by the Oncology Dietetic Practice Group of the Academy of Nutrition and Dietetics. Nutrition science ruled at this event, and “voodoo nutrition” based on conjecture, personal opinion, philosophies, and miracle cures was denied a seat at the table.

Dealing with breast cancer is challenging at the best of times, but in this time of uncertainty and when our health care system is having to quickly adapt to the impact of COVID-19, cancer patients are facing increased challenges and changes to treatment schedules and doctors’ appointments. This can bring additional anxiety and questions around how these changes will impact the success of treatments.